Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endo Pharmaceuticals, a specialty pharmaceutical company, has appointed William Montague to its board of directors.
Subscribe to our email newsletter
Mr Montague, who was CEO and a director of Mark IV Industries, retired in July 2009. Mark IV is a diversified global manufacturer of highly-engineered systems and components for the transportation, industrial and automotive markets.
Mr Montague is also a director of Gibraltar Industries, a manufacturer of products for the building, industrial, and vehicular markets. Mr Montague’s appointment brings the number of Endo board members to eight. Mr Montague will serve as a member of the audit committee of Endo’s board.
Roger Kimmel, chairman of the board of Endo Pharmaceuticals, said: “Bill Montague brings extensive global, operational, financial and acquisition experience and will provide invaluable strategic advice as we continue to build Endo through developing new products, entering new markets and integrating new platforms into our business.”